Wealth Manager - the site for professional investment managers

Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

Brevan Howard revamps trust to reduce fees to ‘2 and 20’

1 Comment
Brevan Howard revamps trust to reduce fees to ‘2 and 20’

Brevan Howard has proposed amending the investment policy of its £388 million BH Global fund to reduce its costs.

BH Global currently invests in other Brevan Howard strategies, incurring fees on each as well as base ongoing charges of 0.75% at the trust level. The present structure is:

BH Global – Current Fees on Underlying Funds
Management Fee Performance Fee Allocation % of net assets
BH Credit Value 1.00% 15% 2.4
BH Master 2.50% 25% 45.3
BH Credit Catalysts 2.00% 20% 15.4
BH Systematic Trading 1.00% 12% 7.5
BH Asia 2.00% 20% 9.8
BH Commodities Strategies 2.00% 20% 6.1
BH – Emg Mkts Local Fixed Income 1.00% 20% 3.2
BH Emerging Markets Strategies 2.50% 20% 0.2
Cash - - 10.3
Sources: Brevan Howard; Numis. Allocation at 28 February 2014. An additional management fee of 0.5% is charged by BH Global.

Under the new policy, BH Global will instead invest directly in the open-ended £2.6 billion Brevan Howard Multi-Strategy Master fund.

This will not change the trust’s management, but will mean its assets no longer incur the same underlying fees.

According to Brevan Howard, this would change the trust’s aggregate costs to a 2% management fee and a performance fee of 20%.

Ewan Lovett-Turner, an analyst at Numis, observed that the previous fee structure had possibly deterred some investors. ‘We believe this had been one of the factors contributing to the persistent discount which has averaged 10% over the last year, and is currently 8.7%,’ he said.

Over the past three years BH Global has returned 13.3%, compared with a 27.7% rise by the FTSE World index.

Leave a comment!

Please sign in or register to comment. It is free to register and only takes a minute or two.
Citywire TV
Play Biotech Growth: we will ride out this storm

Biotech Growth: we will ride out this storm

Geoffrey Hsu of Biotech Growth Trust says the sell-off in biotechnology stocks represents a buying opportunity for long-term investors.

Play Picton: the UK property hotspots for rental income

Picton: the UK property hotspots for rental income

Picton Property Income CEO Michael Morris reveals how he is planning to ride the ‘ripple effect’ as UK economic growth spills out from the capital across the country.

Brewin's Foster talks financial crisis MkII with Allianz's Riddell

Brewin's Foster talks financial crisis MkII with Allianz's Riddell

This week Brewin Dolphin's head of research talks to Mike Riddell, fund manager at Allianz Global Investors, about the forces driving bonds markets in a tumultuous week for markets.

Your Business: Cover Star Club

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

In a buyers’ market for off-the-peg discretionary management, self-funded start-ups begin at an inherent disadvantage

Wealth Manager on Twitter